Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Loxo Oncology Inc (NASDAQ:LOXO)

25.07
Delayed Data
As of Jul 25
 -0.12 / -0.48%
Today’s Change
15.20
Today|||52-Week Range
35.00
-11.88%
Year-to-Date
Why Brocade Communications, Loxo Oncology, and Acadia Healthcare Slumped Today
Jul 14 / MotleyFool.com - Paid Partner Content
New Strong Buy Stocks for July 13th
Jul 13 / Zacks.com - Paid Partner Content
Loxo Oncology (LOXO) Looks Good: Stock Adds 6% in Session
Jul 14 / Zacks.com - Paid Partner Content
 

Today’s Trading

Previous close25.19
Today’s open25.18
Day’s range24.27 - 25.27
Volume62,395
Average volume (3 months)134,969
Market cap$538.2M
Dividend yield--
Data as of 07/25/2016

Growth & Valuation

Earnings growth (last year)+30.72%
Earnings growth (this year)-9.86%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book3.19

Competitors

 Today’s
change
Today’s
% change
CLVSClovis Oncology Inc-0.28-1.97%
SCMPSucampo Pharmaceutic...-0.04-0.35%
ARRYArray Biopharma Inc+0.07+1.93%
RPTPRaptor Pharmaceutica...-0.04-0.66%
Data as of 07/25/2016

Financials

Next reporting dateSeptember 9, 2016
EPS forecast (this quarter)-$0.57
Annual revenue (last year)$0.00
Annual profit (last year)-$35.9M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Josh Bilenker
Executive Director-
Business Operations
Sara Slifka
Corporate headquarters
Stamford, Connecticut

Forecasts

Partner Offers

Search for Jobs